JP2008501038A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501038A5 JP2008501038A5 JP2007515512A JP2007515512A JP2008501038A5 JP 2008501038 A5 JP2008501038 A5 JP 2008501038A5 JP 2007515512 A JP2007515512 A JP 2007515512A JP 2007515512 A JP2007515512 A JP 2007515512A JP 2008501038 A5 JP2008501038 A5 JP 2008501038A5
- Authority
- JP
- Japan
- Prior art keywords
- cell lymphoma
- cell
- lymphoma
- use according
- leukemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52159304P | 2004-05-30 | 2004-05-30 | |
| US60/521,593 | 2004-05-30 | ||
| PCT/US2005/019169 WO2005117891A1 (en) | 2004-05-30 | 2005-05-31 | Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008501038A JP2008501038A (ja) | 2008-01-17 |
| JP2008501038A5 true JP2008501038A5 (cg-RX-API-DMAC7.html) | 2008-06-26 |
| JP5005532B2 JP5005532B2 (ja) | 2012-08-22 |
Family
ID=34971703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007515512A Expired - Lifetime JP5005532B2 (ja) | 2004-05-30 | 2005-05-31 | 10−プロパルギル−10−デアザアミノプテリンを用いるt細胞リンパ腫の治療 |
Country Status (23)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US8263354B2 (en) | 2004-05-30 | 2012-09-11 | Sloan-Kettering Institute For Cancer Research | Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin |
| US20080188479A1 (en) * | 2004-05-30 | 2008-08-07 | Sloan-Kettering Institute For Cancer Research | Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin |
| BRPI0510895A (pt) | 2004-05-30 | 2007-11-27 | Sloan Kettering Inst Cancer | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t |
| EP2179284B1 (en) | 2007-07-31 | 2016-09-28 | Accera, Inc. | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| US20090048262A1 (en) * | 2007-08-17 | 2009-02-19 | Allos Therapeutics, Inc. | Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer |
| US9901578B2 (en) | 2007-08-17 | 2018-02-27 | Allos Therapeutics, Inc. | Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer |
| US20100248249A1 (en) * | 2007-08-17 | 2010-09-30 | Allos Therapeutics, Inc. | Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels |
| US9125881B2 (en) | 2008-07-03 | 2015-09-08 | Accera, Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| WO2010022277A2 (en) * | 2008-08-20 | 2010-02-25 | O'connor Owen A | Combination of 10-propargyl-10-deazaaminopterin and bortezomib for the treatment of cancers |
| WO2011096947A1 (en) * | 2010-02-02 | 2011-08-11 | Allos Therapeutics, Inc. | Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same |
| AU2011261384B2 (en) * | 2010-06-02 | 2015-01-22 | Allos Therapeutics, Inc. | Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin |
| AU2011289638B2 (en) * | 2010-08-10 | 2014-10-30 | Allos Therapeutics, Inc. | Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin |
| WO2013164856A1 (en) | 2012-05-04 | 2013-11-07 | Avra Laboratories Private Limited | A process for preparing intermediates of 10-propargyl-10-deazaaminopterin (pralatrexate) synthesis and the intermediates thereof |
| CN103274943B (zh) * | 2013-05-24 | 2015-01-21 | 苏州明锐医药科技有限公司 | 4-[1-(2-丙炔基)-3,4-二氧代正丁基]苯甲酸酯及其制备方法 |
| US11439643B2 (en) | 2015-06-16 | 2022-09-13 | Acrotech Biopharma Inc. | Combination therapy using belinostat and pralatrexate to treat lymphoma |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4393064A (en) * | 1976-03-05 | 1983-07-12 | Sri International | Process and composition for treatment of leukemia and process for preparing the same |
| US4652533A (en) * | 1983-04-28 | 1987-03-24 | Pandex Laboratories, Inc. | Method of solid phase immunoassay incorporating a luminescent label |
| US4843155A (en) * | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| CA2055813A1 (en) * | 1990-11-20 | 1992-05-21 | Dariush Davalian | Cyclosporin immunoassay |
| US5354751A (en) * | 1992-03-03 | 1994-10-11 | Sri International | Heteroaroyl 10-deazaamino-pterine compounds and use for rheumatoid arthritis |
| US5981592A (en) * | 1995-03-13 | 1999-11-09 | Loma Linda University Medical Center | Method and composition for treating cystic fibrosis |
| US6323205B1 (en) * | 1996-07-17 | 2001-11-27 | Sloan-Kettering Institute For Cancer Research | Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors |
| US6028071A (en) * | 1996-07-17 | 2000-02-22 | Sloan-Kettering Institute For Cancer Research | Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| GB0128510D0 (en) * | 2001-11-28 | 2002-01-23 | Novartis Ag | Organic compounds |
| BRPI0510895A (pt) * | 2004-05-30 | 2007-11-27 | Sloan Kettering Inst Cancer | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t |
-
2005
- 2005-05-31 BR BRPI0510895-0A patent/BRPI0510895A/pt not_active Application Discontinuation
- 2005-05-31 ZA ZA200609266A patent/ZA200609266B/xx unknown
- 2005-05-31 WO PCT/US2005/019170 patent/WO2005117892A1/en not_active Ceased
- 2005-05-31 US US11/141,868 patent/US7622470B2/en not_active Expired - Lifetime
- 2005-05-31 ME MEP-2008-310A patent/ME01087B/me unknown
- 2005-05-31 SI SI200530392T patent/SI1750716T1/sl unknown
- 2005-05-31 EP EP05756183A patent/EP1750716B1/en not_active Expired - Lifetime
- 2005-05-31 US US11/568,254 patent/US7939530B2/en active Active
- 2005-05-31 HR HR20080569T patent/HRP20080569T3/xx unknown
- 2005-05-31 CN CNA2005800173160A patent/CN1960734A/zh active Pending
- 2005-05-31 CA CA2565968A patent/CA2565968C/en not_active Expired - Lifetime
- 2005-05-31 CN CN201210342831.8A patent/CN102824346B/zh not_active Expired - Lifetime
- 2005-05-31 WO PCT/US2005/019169 patent/WO2005117891A1/en not_active Ceased
- 2005-05-31 AT AT05756183T patent/ATE405272T1/de active
- 2005-05-31 AU AU2005249516A patent/AU2005249516B2/en not_active Expired
- 2005-05-31 RS RSP-2008/0470A patent/RS50622B/sr unknown
- 2005-05-31 NZ NZ551082A patent/NZ551082A/en not_active IP Right Cessation
- 2005-05-31 JP JP2007515512A patent/JP5005532B2/ja not_active Expired - Lifetime
- 2005-05-31 MX MXPA06013559A patent/MXPA06013559A/es active IP Right Grant
- 2005-05-31 DK DK05756183T patent/DK1750716T3/da active
- 2005-05-31 PT PT05756183T patent/PT1750716E/pt unknown
- 2005-05-31 ES ES05756183T patent/ES2313365T3/es not_active Expired - Lifetime
- 2005-05-31 KR KR1020117012373A patent/KR101189693B1/ko not_active Expired - Lifetime
- 2005-05-31 DE DE602005009176T patent/DE602005009176D1/de not_active Expired - Lifetime
- 2005-05-31 NZ NZ576849A patent/NZ576849A/en not_active IP Right Cessation
- 2005-05-31 PL PL05756183T patent/PL1750716T3/pl unknown
-
2006
- 2006-12-22 NO NO20065971A patent/NO337276B1/no unknown
-
2009
- 2009-10-21 US US12/603,117 patent/US8299078B2/en not_active Expired - Lifetime
-
2012
- 2012-10-29 US US13/663,234 patent/US20130053391A1/en not_active Abandoned